Skip to main content

Sientra Faces Lymphoma Lawsuit Over Textured Breast Implants

Sientra Faces Lymphoma Lawsuit Over Textured Breast Implants

Sientra Faces Lymphoma Lawsuit Over Textured Breast Implants

Introduction

Sientra is facing allegations similar to Allergan over its silicone implants by a Tennessee woman who claims that the textured breast implants made in Brazil resulted in her breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare type of cancer in the surrounding tissue.

The lawsuit was filed by Kelly Painter-Hart and her husband, Seth Hart, in the U.S. District Court for the Eastern District of Tennessee. According to the lawsuit filed, Painter-Hart had bilateral mastectomies in November 2013 as a precautionary measure over breast cancer and was implanted with Sientra textured oval-shaped silicone gel implants.

In September 2019, she went to her surgeon complaining of swelling in her right breast, and in October, she was diagnosed with BIA-ALCL, following which she removed the implants surgically a month later. The lawsuit claims that the couple and her surgeon were never warned of the risk associated with the textured breast implants.

The lawsuit further states that the implants were made by Silimed, and the manufacturer had acknowledged its failure to follow good manufacturing practices in a first-quarter report published in 2015. These practices result in negligently manufactured, overly textured, rough implant shells containing foreign and adulterated silicone particles, fragments, implant materials, and residues, which triggers T-cell lymphoma and over time, BIA-ALCL, the lawsuit claims.

The couple is seeking damages based on negligence, manufacturing defects, failure to warn, and breach of express and implied warranties for the pain and suffering, and the permanent physical impairment and disfigurement caused, along with punitive damages.

Allergan is also facing similar lawsuits over its recalled “Biocell” textured breast implants. The Food and Drug Administration (FDA) recently indicated that out of the 733 BIA-ALCL cases reported, where the manufacturer has been identified, 620 are linked to breast implants sold by Allergan.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest News

title demo for news

Categories: Settlements

created dropdown in quarterly-results page in localy, and explore all the component codes 

Zantac Settles 4,000 Lawsuits in U.S. Courts

Categories: General

Sanofi has announced a settlement agreement regarding approximately 4,000 Zantac cancer lawsuits filed in state courts across the country.

Valsartan Recall Lawsuit Set for Trial

Categories: General

Years after the initiation of Valsartan recalls, the U.S. District Judge overseeing lawsuits filed by individuals harmed by tainted versions of…

Our Legal Drafting Services    
start @ $25 per hour.